Hepatocellular carcinoma during pregnancy: Is hepatocellular carcinoma more aggressive in pregnant patients?

Kang Kook Choi, Young Ju Hong, Sae-Byeol Choi, Young Nyun Park, Jin Sub Choi, Woo Jung Lee, Kyung Sik Kim

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background/purpose: Hepatocellular carcinoma (HCC) during pregnancy is a very rare condition and is believed to have a worse prognosis than HCC in non-pregnant women. We evaluated the prognosis and the diagnostic and therapeutic strategies for HCC in pregnant women. Methods: We retrospectively analyzed 4 cases in our hospital and 44 cases described in the medical literature since 1957; we also compared the cases reported before 1995 and those reported during/after 1995. Results: The overall 6-month and 1-, 2-, and 3-year survival rates in the patients reported in the literature were 50, 29.5, 18.2, and 13.6%, respectively (n = 44). The mean ages at diagnosis before and during/after 1995 were 31.4 ± 7.2 and 28.9 ± 4.4 years, respectively (P = 0.113). The following characteristics were significantly more common in the later group: fewer pregnancies; the absence of advanced signs or symptoms; receipt of therapy; tendency to undergo surgery; and higher 6-month and 1-, 2-, and 3-year survival rates. The median survivals of the groups before and during/after 1995 were 18 and 25.5 months, respectively (P < 0.001). Conclusions: The morbidity and mortality of HCC during pregnancy has improved over time, as diagnoses have tended to be made earlier and patients have tended to receive surgical and other treatments.

Original languageEnglish
Pages (from-to)422-431
Number of pages10
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume18
Issue number3
DOIs
Publication statusPublished - 2011 May 1

Fingerprint

Hepatocellular Carcinoma
Pregnancy
Survival Rate
Signs and Symptoms
Pregnant Women
Therapeutics
Morbidity
Survival
Mortality

Keywords

  • Hepatocellular carcinoma
  • Pregnancy

ASJC Scopus subject areas

  • Surgery
  • Hepatology

Cite this

Hepatocellular carcinoma during pregnancy : Is hepatocellular carcinoma more aggressive in pregnant patients? / Choi, Kang Kook; Hong, Young Ju; Choi, Sae-Byeol; Park, Young Nyun; Choi, Jin Sub; Lee, Woo Jung; Kim, Kyung Sik.

In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 18, No. 3, 01.05.2011, p. 422-431.

Research output: Contribution to journalArticle

Choi, Kang Kook ; Hong, Young Ju ; Choi, Sae-Byeol ; Park, Young Nyun ; Choi, Jin Sub ; Lee, Woo Jung ; Kim, Kyung Sik. / Hepatocellular carcinoma during pregnancy : Is hepatocellular carcinoma more aggressive in pregnant patients?. In: Journal of Hepato-Biliary-Pancreatic Sciences. 2011 ; Vol. 18, No. 3. pp. 422-431.
@article{3ab16e6eecec4bab9b3fd9889eafa459,
title = "Hepatocellular carcinoma during pregnancy: Is hepatocellular carcinoma more aggressive in pregnant patients?",
abstract = "Background/purpose: Hepatocellular carcinoma (HCC) during pregnancy is a very rare condition and is believed to have a worse prognosis than HCC in non-pregnant women. We evaluated the prognosis and the diagnostic and therapeutic strategies for HCC in pregnant women. Methods: We retrospectively analyzed 4 cases in our hospital and 44 cases described in the medical literature since 1957; we also compared the cases reported before 1995 and those reported during/after 1995. Results: The overall 6-month and 1-, 2-, and 3-year survival rates in the patients reported in the literature were 50, 29.5, 18.2, and 13.6{\%}, respectively (n = 44). The mean ages at diagnosis before and during/after 1995 were 31.4 ± 7.2 and 28.9 ± 4.4 years, respectively (P = 0.113). The following characteristics were significantly more common in the later group: fewer pregnancies; the absence of advanced signs or symptoms; receipt of therapy; tendency to undergo surgery; and higher 6-month and 1-, 2-, and 3-year survival rates. The median survivals of the groups before and during/after 1995 were 18 and 25.5 months, respectively (P < 0.001). Conclusions: The morbidity and mortality of HCC during pregnancy has improved over time, as diagnoses have tended to be made earlier and patients have tended to receive surgical and other treatments.",
keywords = "Hepatocellular carcinoma, Pregnancy",
author = "Choi, {Kang Kook} and Hong, {Young Ju} and Sae-Byeol Choi and Park, {Young Nyun} and Choi, {Jin Sub} and Lee, {Woo Jung} and Kim, {Kyung Sik}",
year = "2011",
month = "5",
day = "1",
doi = "10.1007/s00534-010-0345-6",
language = "English",
volume = "18",
pages = "422--431",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Hepatocellular carcinoma during pregnancy

T2 - Is hepatocellular carcinoma more aggressive in pregnant patients?

AU - Choi, Kang Kook

AU - Hong, Young Ju

AU - Choi, Sae-Byeol

AU - Park, Young Nyun

AU - Choi, Jin Sub

AU - Lee, Woo Jung

AU - Kim, Kyung Sik

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Background/purpose: Hepatocellular carcinoma (HCC) during pregnancy is a very rare condition and is believed to have a worse prognosis than HCC in non-pregnant women. We evaluated the prognosis and the diagnostic and therapeutic strategies for HCC in pregnant women. Methods: We retrospectively analyzed 4 cases in our hospital and 44 cases described in the medical literature since 1957; we also compared the cases reported before 1995 and those reported during/after 1995. Results: The overall 6-month and 1-, 2-, and 3-year survival rates in the patients reported in the literature were 50, 29.5, 18.2, and 13.6%, respectively (n = 44). The mean ages at diagnosis before and during/after 1995 were 31.4 ± 7.2 and 28.9 ± 4.4 years, respectively (P = 0.113). The following characteristics were significantly more common in the later group: fewer pregnancies; the absence of advanced signs or symptoms; receipt of therapy; tendency to undergo surgery; and higher 6-month and 1-, 2-, and 3-year survival rates. The median survivals of the groups before and during/after 1995 were 18 and 25.5 months, respectively (P < 0.001). Conclusions: The morbidity and mortality of HCC during pregnancy has improved over time, as diagnoses have tended to be made earlier and patients have tended to receive surgical and other treatments.

AB - Background/purpose: Hepatocellular carcinoma (HCC) during pregnancy is a very rare condition and is believed to have a worse prognosis than HCC in non-pregnant women. We evaluated the prognosis and the diagnostic and therapeutic strategies for HCC in pregnant women. Methods: We retrospectively analyzed 4 cases in our hospital and 44 cases described in the medical literature since 1957; we also compared the cases reported before 1995 and those reported during/after 1995. Results: The overall 6-month and 1-, 2-, and 3-year survival rates in the patients reported in the literature were 50, 29.5, 18.2, and 13.6%, respectively (n = 44). The mean ages at diagnosis before and during/after 1995 were 31.4 ± 7.2 and 28.9 ± 4.4 years, respectively (P = 0.113). The following characteristics were significantly more common in the later group: fewer pregnancies; the absence of advanced signs or symptoms; receipt of therapy; tendency to undergo surgery; and higher 6-month and 1-, 2-, and 3-year survival rates. The median survivals of the groups before and during/after 1995 were 18 and 25.5 months, respectively (P < 0.001). Conclusions: The morbidity and mortality of HCC during pregnancy has improved over time, as diagnoses have tended to be made earlier and patients have tended to receive surgical and other treatments.

KW - Hepatocellular carcinoma

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=79958248293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958248293&partnerID=8YFLogxK

U2 - 10.1007/s00534-010-0345-6

DO - 10.1007/s00534-010-0345-6

M3 - Article

C2 - 21116657

AN - SCOPUS:79958248293

VL - 18

SP - 422

EP - 431

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 3

ER -